Event Listings

This event will provide first-hand information from the experts which are deeply involved in promoting advanced health technology assessment and patient-access models in Turkey and wish to have a voice in such discussions. This will be an ideal platform for a unique, multi-stakeholder discussion and a reliable source of information for all manufacturers who are already active or planning to extend their business in Turkey.

Main topics this year include:

·         Health transformation programme and new policies

·         Financing healthcare infrastructure and best PPP practices and options

·         Long-term opportunities for investment in the Turkish healthcare market

·         Healthcare services delivery – management and funding

·         Healthcare financing reform and the broadening of the  private health insurance market

·         E-health, telemedicine and medical information technology

·         Technology expertise to increase Turkeys medical equipment exports

·         Medical tourism

·         Turkey pharmaceutical insight.

Being attended by global leaders, this event will be a great place to network, finding out about exciting new products, as well as laws and regulations which affect the industry.

BioPharma Asia Convention is the only event that brings together senior level executives from global and regional pharma companies, biotechs, CMOs, CROs, academic institutions, investors and all other industrial stakeholders to assess the latest industrial trends, partnership models and solutions in Asia.

 

This is the largest biopharmaceutical gathering in Asia featuring multiple conferences, summits and seminars that covers the entire value chain of the biopharma industry. Biopharma Asia Convention 2012 will show you how you can access the important markets in Asia that matters most to your business. Over four days, more than 2,000 decision makers from leading biopharmaceutical companies from Asia and globally will gather at this event.

The IPhEB Forum covers the global pharmaceutical industry’s topical issues and recent developments as well as their connection with the problems of the Russian pharmaceutical market. The event provides an opportunity for substantive topical discussions, risks assessing, prospective decision-making, productive experience exchange and promising meetings.

     

The IPhEB Forum is accompanied with the exhibition of the same title to be held on April 3 to 5 in Manège Central Exhibition Hall.

WPMC 2012 is a must-attend international event you can never afford to miss. It brings top decision makers of world's well-known pharmas and potential partners from both China and abroad to your side. With topics covering regulatory compliance, CMO/ outsourcing partnership, operational excellence, quality assurance and facility management, etc, WPMC 2012 is expecting over 200 attendees from pharmas, biotech companies, contract manufacturing organizations, device/equipment suppliers, consultancies and other service providers.

For more information, please feel free to contact
Kathy Guo
Tel: +86 21 6052 0431
Fax: +86 21 6380 0607
Email: kathy.guo@s-isc.com

Endorsers: Shanghai Biopharmaceutics Industry Association
              China National Association of Pharmaceutical and Medical Equipment Industry Technical Market

Join your peers and colleagues at our Pharmaceutical Anti-Counterfeiting Conference.

The objective of this conference is to provide communication, education and networking opportunities for scientists engaged in Pharmaceutical Anti-Counterfeiting whether in academia, biotech or industry.Attendees will hear world-class speakers discussing the challenges and opportunities facing the Pharmaceutical Anti-Counterfeiting field.

This event will mainly focus on 1) regulatory guidelines in SEA, China and Korea, 2) best practices in drug registration/combination products registration in different markets in particular Japan, Korea, China, Indonesia, Vietnam, Thailand and Philippines 3) Lifecycle management of products

• Major elements in setting up drug registration strategies especially in key Asian markets such as  Japan, Korea, China, Indonesia, Vietnam, Thailand and Taiwan
• Drug applications for new drugs, orphan drugs, and combination drugs in various markets
• Updates on regulatory guidelines in various markets
• Obtain essential regulatory advice on combination products registration in Europe, USA and Asia-Pacific 
• Packaging requirements for combination products
• Regulatory requirements for different type of combination products in different Asian markets
• Priority Reviews
• Ensuring pre-clinical and clinical studies comply to key Asian regulations including GLP, GCP and FDA requirements
• Improving the procedures and approval process for various product types including biosimilars and generics
• Marketing and life cycle management to ensure the success of product
• Strategies for entry into highly localized markets such as Japan
• Regulatory requirements on conducting multi-regional / national clinical trials in various markets in Asia.
• Effective industry communication between regulatory agencies and pharmaceutical companies
• Asean harmonization on pharmaceutical products – comparing it to requirements in EU and US

 

Quote BSM to qualify for the 10% discount

This event will bring together experts responsible for key Asian markets globally and locally to discuss how the current changing environments will impact on market access in these markets and as a result affect global strategies. This event will be particularly focused on those who consider these markets a priority worthy of further understanding. Participants will also learn how to ensure their products are demonstrating value in correct terms, to the right people in each market.

Pharmaceutical outsourcing is growing exponentially amidst challenging price restrictions, US health care reforms and reduced revenues.  The pharmaceutical and outsourcing summit addresses the urgent need for pharma to identify and locate the best outsourcing partnerships and solutions to stay competitive in an uncertain climate whilst addressing heightened regulatory pressures and need to maintain high quality standards.  The summit will address the growing outsourcing requirements in contract manufacturing, bulk, fill finish, drug delivery and formulation, research & development API sourcing.